Treatments:Cancer
From Proteopedia
(Difference between revisions)
Line 22: | Line 22: | ||
* Evista - Generic: Raloxifene | * Evista - Generic: Raloxifene | ||
* Fareston - Generic: Toremifene | * Fareston - Generic: Toremifene | ||
- | * Nolvadex - Generic: Tamoxifen | + | * [[Nolvadex]] - Generic: Tamoxifen |
=====Multiple Receptor Tyrosine Kinase ([[VEGFR]], PDGFR, [[EGFR]], KIT, Abl) Inhibitor===== | =====Multiple Receptor Tyrosine Kinase ([[VEGFR]], PDGFR, [[EGFR]], KIT, Abl) Inhibitor===== | ||
* [[Gleevec]] - Generic: Imatinib | * [[Gleevec]] - Generic: Imatinib |
Revision as of 03:31, 23 October 2012
Anti-CD20 Monoclonal AntibodyB-Raf Kinase Inhibitor
Chemotherapy
Dihydrofolate Reductase Inhibitor
Epidermal Growth Factor Receptor Inhibitor
Estrogen Receptor Modulator
Multiple Receptor Tyrosine Kinase (VEGFR, PDGFR, EGFR, KIT, Abl) Inhibitor
Vascular Endothelial Growth Factor Inhibitor
|
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis